Abstract
Hemorrhage continues to be one of the leading causes of death following trauma. Trauma patients are susceptible to the early development of coagulopathy and the most severely injured patients are coagulopathic on hospital admission. Hypothermia, acidosis, and dilution from standard resuscitation can worsen the presenting coagulopathy and perpetuate bleeding. Early identification of coagulopathy is dependent on clinical awareness and point of care laboratory values. Routinely used laboratory coagulation parameters fail to adequately describe this state. Thrombelastography is a test that can be done at the bedside and uses whole blood to provide a functional evaluation of coagulation. Rapid diagnosis of coagulopathy, followed by prevention or correction of hypothermia and acidosis should be a priority during the initial evaluation and resuscitation. Judicious use of resuscitation fluids and early replacement of coagulation factors will help prevent iatrogenic hemodilution. This review covers the pathophysiology as well as the clinical and laboratory diagnosis of coagulopathy. Prevention and treatment strategies are discussed, including early transfusion of coagulation factors during massive transfusion and the use of recombinant factor VIIa. Damage control resuscitation is briefly discussed, and it involves the combination of hypotensive resuscitation and hemostatic resuscitation. Finally, a description of the use of fresh whole blood in the military setting is included. Its use has been proven to be safe and beneficial in this setting and warrants further investigation as an adjunct to the management of civilian trauma patients.
Article PDF
Similar content being viewed by others
Avoid common mistakes on your manuscript.
References
Centers for Disease Control and Prevention: Web-based Injury Statistics Query and Reporting System. Atlanta: US Department of Health and Human Services, CDC, National Center for Injury Prevention and Control, 2003
Sauaia A, Moore FA, Moore EE, et al. Epidemiology of trauma deaths: a reassessment. J Trauma 1995;38:185–193
Acosta JA, Yang JC, Winchell RJ, et al. Lethal injuries and time to death in a level I trauma center. J Am Coll Surg 1998;186:528–533
Stewart RM, Myers JG, Dent DL, et al. Seven hundred fifty-three consecutive deaths in a level I trauma center: the argument for injury prevention. J Trauma 2003;54:66–70; discussion 70–71
MacLeod JB, Lynn M, McKenney MG, et al. Early coagulopathy predicts mortality in trauma. J Trauma 2003;55:39–44
Rosenberg RD, Aird WC. Vascular-bed–specific hemostasis and hypercoagulable states. N Engl J Med 1999;340:1555–1564 [Review]
Esmon CT, Owen WG. Identification of an endothelial cell cofactor for thrombin-catalyzed activation of protein C. Proc Natl Acad Sci USA 1981;78:2249–2252
Hulka F, Mullins RJ, Frank EH. Blunt brain injury activates the coagulation process. Arch Surg 1996;131:923–927
Faringer PD, Mullins RJ, Johnson RL, Trunkey DD. Blood component supplementation during massive transfusion of AS-1 red cells in trauma patients. J Trauma 1993;34:481–485; discussion 485–487
Cosgriff N, Moore EE, Sauaia A, et al. Predicting life-threatening coagulopathy in the massively transfused trauma patient: hypothermia and acidoses revisited. J Trauma 1997;42:857–861; discussion 861–862
Brohi K, Singh J, Heron M, Coats T. Acute traumatic coagulopathy. J Trauma 2003;54:1127–1130
Weil MH, Afifi AA. Experimental and clinical studies on lactate and pyruvate as indicators of the severity of acute circulatory failure (shock). Circulation 1970;41:989–1001
Gentilello LM. Practical approaches to hypothermia. In: Maull KI, Cleveland HC, Feliciano DV, et al., editors, Advances in Trauma and Critical Care, vol. 9, St. Louis, Mosby, 1994;39–79
Kermode JC, Zheng Q, Milner EP. Marked temperature dependence of the platelet calcium signal induced by human von Willebrand factor. Blood 1999;94:199–207
Hess JR, Hiippala S. Optimizing the use of blood products in trauma care. Crit Care 2005;9(Suppl 5):S10–S14
Ferrara A, MacArthur JD, Wright HK, et al. Hypothermia and acidosis worsen coagulopathy in the patient requiring massive transfusion. Am J Surg 1990;160:515–518
Johnston TD, Chen Y, Reed RL 2nd. Functional equivalence of hypothermia to specific clotting factor deficiencies. J Trauma 1994;37:413–417
Meng ZH, Wolberg AS, Monroe DM 3rd, et al. The effect of temperature and pH on the activity of factor VIIa: implications for the efficacy of high-dose factor VIIa in hypothermic and acidotic patients. J Trauma 2003;55:886–891
Hess JR, Lawson JH. The coagulopathy of trauma versus disseminated intravascular coagulation. J Trauma 2006;60(Suppl 6):S12–S19 [Review]
Martini WZ, Pusateri AE, Uscilowicz JM, et al. Independent contributions of hypothermia and acidosis to coagulopathy in swine. J Trauma 2005;58:1002–1009; discussion 1009–1010
Waters JH, Gottlieb A, Schoenwald P, et al. Normal saline versus lactated Ringer’s solution for intraoperative fluid management in patients undergoing abdominal aortic aneurysm repair: an outcome study. Anesth Analg 2001;93:817–822
Zuckerman L, Cohen E, Vagher JP, et al. Comparison of thrombelastography with common coagulation tests. Thromb Haemost 1981;46:752–756
Kaufmann CR, Dwyer KM, Crews JD, et al. Usefulness of thrombelastography in assessment of trauma patient coagulation. J Trauma 1997;42:716–720; discussion 720–722
Zambruni A, Thalheimer U, Leandro G, et al. Thromboelastography with citrated blood: comparability with native blood, stability of citrate storage and effect of repeated sampling. Blood Coagul Fibrinolysis 2004;15:103–107
Pivalizza EG, Pivalizza PJ, Gottschalk LI, et al. Celite-activated thrombelastography in children. J Clin Anesth 2001;13:20–23
Gorton HJ, Warren ER, Simpson NA, et al. Thromboelastography identifies sex-related differences in coagulation. Anesth Analg 2000;91:1279–1281
Manspeizer HE, Imai M, Frumento RJ, et al. Arterial and venous Thrombelastograph variables differ during cardiac surgery. Anesth Analg 2001;93:277–281
Camenzind V, Bombeli T, Seifert B, et al. Citrate storage affects Thrombelastograph analysis. Anesthesiology 2000;92:1242–1249
Vig S, Chitolie A, Bevan DH, et al. Thromboelastography: a reliable test? Blood Coagul Fibrinolysis 2001;12:555–561
Rajwal S, Richards M, O’Meara M. The use of recalcified citrated whole blood—a pragmatic approach for thromboelastography in children. Paediatr Anaesth 2004;14:656–60
Gentilello LM, Cobean RA, Offner PJ, et al. Continuous arteriovenous rewarming: rapid reversal of hypothermia in critically ill patients. J Trauma 1992;32:316–325; discussion 325–327
Gentilello LM, Jurkovich GJ, Stark MS, et al. Is hypothermia in the victim of major trauma protective or harmful? A randomized, prospective study. Ann Surg 1997;226:439–447; discussion 447–449
Kiraly LN, Differding JA, Enomoto TM, et al. Resuscitation with normal saline (NS) vs. lactated ringers (LR) modulates hypercoagulability and leads to increased blood loss in an uncontrolled hemorrhagic shock swine model. J Trauma 2006;61:57–64; discussion 64–65
Entholzner EK, Mielke LL, Calatzis AN, et al. Coagulation effects of a recently developed hydroxyethyl starch (HES 130/0.4) compared to hydroxyethyl starches with higher molecular weight. Act Anesth Scand 2000;44:1116–1121
Jamnicki M, Zollinger A, Seifert B, et al. Compromised blood coagulation: an in vitro comparison of hydroxyethyl starch 130/0.4 and hydroxyethyl starch 200/0.5 using thrombelastography. Anesth Analg 1998;87:989–993
Langeron O, Doelberg M, Ang ET, et al. Voluven, a lower substituted novel hydroxyethyl starch (HES 130/0.4), causes fewer effects on coagulation in major orthopedic surgery than HES 200/0.5. Anesth Analg 2001;92:855–862
Fenger-Eriksen C, Anker-Moller E, Heslop J, et al. Thrombelastographic whole blood clot formation after ex vivo addition of plasma substitutes: improvements of the induced coagulopathy with fibrinogen concentrate. Br J Anaesth 2005;94:324–329
Martin G, Bennett-Guerrero E, Wakeling H, et al. A prospective, randomized comparison of thromboelastographic coagulation profile in patients receiving lactated Ringer’s solution, 6% hetastarch in a balanced-saline vehicle, or 6% hetastarch in saline during major surgery. J Cardiothorac Vasc Anesth 2002;16:441–446
Gan TJ, Bennett-Guerrero E, Phillips-Bute B, et al. Hextend, a physiologically balanced plasma expander for large volume use in major surgery: a randomized phase III clinical trial. Hextend Study Group. Anesth Analg 1999;88:992–998
Gross D, Landau EH, Assalia A, et al. Is hypertonic saline resuscitation safe in “uncontrolled” hemorrhagic shock? J Trauma 1988;28:751–756
Gross D, Landau EH, Klin B, Krausz MM. Quantitative measurement of bleeding following hypertonic saline therapy in “uncontrolled” hemorrhagic shock. J Trauma 1989;29:79–83
Krausz MM, Landau EH, Klin B, et al. Hypertonic saline treatment of uncontrolled hemorrhagic shock at different periods from bleeding. Arch Surg 1992;127:93–96
Reed RL 2nd, Johnston TD, Chen Y, et al. Hypertonic saline alters plasma clotting times and platelet aggregation. J Trauma 1991;31:8–14
Wilder DM, Reid TJ, Bakaltcheva IB. Hypertonic resuscitation and blood coagulation: in vitro comparison of several hypertonic solutions for their action on platelets and plasma coagulation. Thromb Res 2002;107:255–261
Watters JM, Tieu BH, Differding JA, et al. A single bolus of 3% hypertonic saline with 6% dextran provides optimal initial resuscitation after uncontrolled hemorrhagic shock. J Trauma 2006;61:75–81
Kauvar DS, Wade CE. The epidemiology and modern management of traumatic hemorrhage: US and international perspectives. Crit Care 2005;9(Suppl 5):S1–S9
Cannon W, Frawer J, Cowell E. The preventive treatment of wound shock. JAMA 1918;70:618–621
Bickell WH, Wall MJ, Pepe PE, et al. Immediate versus delayed fluid resuscitation for hypotensive patients with penetrating torso injuries. N Engl J Med 1994;331:1105–1109
NATO Emergency War Surgery Handbook. 2004
Dutton RP, Mackenzie CF, Scalea TM. Hypotensive resuscitation during active hemorrhage: impact on in-hospital mortality. J Trauma 2002;52:1141–1146
Holcomb JB. Fluid resuscitation in modern combat casualty care: lessons learned from Somalia. J Trauma 2003;54(Suppl 5):S46–51
Carrico CJ, Holcomb JB, Chaudry IH. PULSE Trauma Work Group. Post Resuscitative and Initial Utility of Life Saving Efforts. Scientific Priorities and Strategic Planning for Resuscitation Research and Life Saving Therapy Following Traumatic Injury: Report of the PULSE Trauma Work Group. Acad Emerg Med 2002;9:621–626
Sondeen JL, Coppes VG, Holcomb JB. Blood pressure at which rebleeding occurs after resuscitation in swine with aortic injury. J Trauma 2003;54(Suppl):S110–117
Wade CE, Holcomb JB. Endpoints in clinical trials of fluid resuscitation of patients with traumatic injuries. Transfusion 2005;45:4S–8S
Lozano ML, Rivera J, Gonzalez-Conejero R, et al. Loss of high-affinity thrombin receptors during platelet concentrate storage impairs the reactivity of platelets to thrombin. Transfusion 1997;37:368–375
Hirshberg A, Dugas M, Banez EI, et al. Minimizing dilutional coagulopathy in exsanguinating hemorrhage: a computer simulation. J Trauma 2003;54:454–463
Hewson JR, Neame PB, Kumar N, et al. Coagulopathy related to dilution and hypotension during massive transfusion. Crit Care Med 1985;13:387–391
Kauvar DS, Holcomb JB, Norris GC, et al. Fresh whole blood transfusion: a controversial military practice. J Trauma 2006;61:181–184
Mohr R, Goor DA, Yellin A, et al. Fresh blood units contain large potent platelets that improve hemostasis after open heart operations. Ann Thorac Surg 1992;53:650–654
Martinowitz U, Kenet G, Segal E, et al. Recombinant activated factor VII for adjunctive hemorrhage control in trauma. J Trauma 2001;51:431–438; discussion 438–439
Levy JH. Novel pharmacologic approaches to reduce bleeding. Can J Anaesth 2003;50(Suppl 6):S26–30 [Review]
Dutton RP, McCunn M, Hyder M, et al. Factor VIIa for correction of traumatic coagulopathy. J Trauma 2004;57:709–718; discussion 718–719
Boffard KD, Riou B, Warren B, et al. the NovoSeven Trauma Study Group. Recombinant factor VIIa as adjunctive therapy for bleeding control in severely injured trauma patients: two parallel randomized, placebo-controlled, double-blind clinical trials. J Trauma 2005;59:8–15; discussion 15–18
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Tieu, B.H., Holcomb, J.B. & Schreiber, M.A. Coagulopathy: Its Pathophysiology and Treatment in the Injured Patient. World J Surg 31, 1055–1065 (2007). https://doi.org/10.1007/s00268-006-0653-9
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00268-006-0653-9